BiotechTube

Gabapentin + Gabapentin + Gabapentin + Gabapentin

ApprovedTerminated
1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

PK Properties Of Gabapentin In Subjects With Impaired Renal Function

Conditions

PK Properties Of Gabapentin In Subjects With Impaired Renal Function

Trial Timeline

Oct 1, 2007 → Dec 1, 2007

NCT ID
NCT00584779

About Gabapentin + Gabapentin + Gabapentin + Gabapentin

Gabapentin + Gabapentin + Gabapentin + Gabapentin is a approved stage product being developed by Pfizer for PK Properties Of Gabapentin In Subjects With Impaired Renal Function. The current trial status is terminated. This product is registered under clinical trial identifier NCT00584779. Target conditions include PK Properties Of Gabapentin In Subjects With Impaired Renal Function.

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00584779ApprovedTerminated